Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-01 · accession 0001765581-25-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-05 | 2025-05-01+ | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale | $117.57 | -1,500 | 439.3K | -0.3% | -$176.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-05-02 | S | D | 500 | $120.00 | 438,807 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-05-01 | S | D | 1,000 | $116.35 | 439,307 | D | — | — |